Dr. Wirth on the Use of Lenvatinib in Hypertensive Patients With Thyroid Cancer

Поделиться
HTML-код
  • Опубликовано: 11 сен 2024
  • Lori J. Wirth, MD, associate professor, Medicine, Harvard Medical School, medical director, Center for Head and Neck Cancers, Massachusetts General Hospital, discusses the use of lenvatinib (Lenvima) in hypertensive patients with thyroid cancer.

Комментарии • 1